Pacira Pharmaceuticals Aktie

Kaufen
Verkaufen
16,30 EUR +0,40 EUR +2,52 %
17,38 USD +0,33 USD +1,94 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 732,41 Mio. EUR

KGV 41,80 Div. Rendite 0,00%

WKN A1H68T

ISIN US6951271005

Symbol PCRX


Pacira Pharmaceuticals Aktie Analyse

11.06.19 Pacira Pharmaceuticals overweight Barclays Capital
09.04.18 Pacira Pharmaceuticals Buy H.C. Wainwright & Co.
19.01.18 Pacira Pharmaceuticals Buy Seaport Global Securities
04.01.18 Pacira Pharmaceuticals Buy Canaccord Adams
09.11.17 Pacira Pharmaceuticals Buy H.C. Wainwright & Co.
19.10.17 Pacira Pharmaceuticals Buy Needham & Company, LLC
22.08.17 Pacira Pharmaceuticals Buy Needham & Company, LLC
05.05.17 Pacira Pharmaceuticals Buy Mizuho
13.04.17 Pacira Pharmaceuticals Outperform RBC Capital Markets
23.03.17 Pacira Pharmaceuticals Buy Mizuho
21.03.17 Pacira Pharmaceuticals overweight Barclays Capital
02.03.17 Pacira Pharmaceuticals Buy H.C. Wainwright & Co.
22.02.17 Pacira Pharmaceuticals Buy Canaccord Adams
03.01.17 Pacira Pharmaceuticals Buy H.C. Wainwright & Co.
21.12.16 Pacira Pharmaceuticals Buy Mizuho
03.11.16 Pacira Pharmaceuticals Buy Mizuho
19.10.16 Pacira Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
25.05.16 Pacira Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
03.05.16 Pacira Pharmaceuticals Buy Mizuho
19.04.16 Pacira Pharmaceuticals Buy Mizuho
31.07.15 Pacira Pharmaceuticals overweight Barclays Capital
01.05.15 Pacira Pharmaceuticals Buy Brean Capital
04.03.15 Pacira Pharmaceuticals Buy Brean Capital
03.03.15 Pacira Pharmaceuticals Buy Canaccord Adams
02.03.15 Pacira Pharmaceuticals overweight Barclays Capital
24.02.15 Pacira Pharmaceuticals Buy Brean Capital
12.02.15 Pacira Pharmaceuticals Buy Canaccord Adams